MRP of 3 anti-cancer drugs to come down due to exemption from custom duty and reduction in GST Read more
AstraZeneca India receives CDSCO approval for Durvalumab for specified additional indication Read more
AstraZeneca’s Durvalumab gets CDSCO nod to treat locally advanced or metastatic biliary tract cancer Read more